These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP. J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [Abstract] [Full Text] [Related]
3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M. Ann Acad Med Stetin; 2000 Dec; 46():217-29. PubMed ID: 11712306 [Abstract] [Full Text] [Related]
4. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS. Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485 [Abstract] [Full Text] [Related]
5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG. J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [Abstract] [Full Text] [Related]
6. Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG. Cancer; 2003 Sep 01; 98(5):955-61. PubMed ID: 12942562 [Abstract] [Full Text] [Related]
10. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
11. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection. Nielsen ME, Bastian PJ, Palapattu GS, Trock BJ, Schoenberg MP, Chan T, Rogers CG. Urology; 2007 Dec 01; 70(6):1091-5. PubMed ID: 18158024 [Abstract] [Full Text] [Related]
12. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R. J Urol; 1995 Jan 01; 153(1):47-52. PubMed ID: 7966789 [Abstract] [Full Text] [Related]
13. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer. Izawa JI, Chin JL, Winquist E. Can J Urol; 2006 Jun 01; 13 Suppl 3():48-53. PubMed ID: 16818012 [Abstract] [Full Text] [Related]
14. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. BJU Int; 2007 Jul 01; 100(1):33-6. PubMed ID: 17552951 [Abstract] [Full Text] [Related]
15. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE. Cancer; 2009 Feb 15; 115(4):770-5. PubMed ID: 19152431 [Abstract] [Full Text] [Related]
16. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Choong NW, Quevedo JF, Kaur JS. Cancer; 2005 Mar 15; 103(6):1172-8. PubMed ID: 15700264 [Abstract] [Full Text] [Related]
17. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI. J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151 [Abstract] [Full Text] [Related]
18. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Cancer; 2007 Jul 01; 110(1):62-7. PubMed ID: 17542024 [Abstract] [Full Text] [Related]
19. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. J Urol; 2010 May 01; 183(5):1757-63. PubMed ID: 20299059 [Abstract] [Full Text] [Related]
20. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG. J Urol; 2009 May 01; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]